NASDAQ · Biotechnology

Axcella Health Inc. (AXLA) Stock

$4.58 +0.00% NASDAQ: AXLA Healthcare

Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators.

Valuation

MetricValue
Price$4.58
Market Cap$12.50M
P/E Ratio-3.61
P/B Ratio70.41
P/S Ratio0.00
EPS (TTM)$-1.27
52-Week High$4.58
52-Week Low$0.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-620.40%
ROA-428.94%
ROCE-1460.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.52
Current Ratio1.21

Annual Financials (USD)

Metric20182019202020212022
Revenue$0$0$0$0$0
Operating Profit$-34.0M$-57.0M$-54.0M$-62.0M$-73.0M
Net Profit$-36.0M$-60.0M$-59.0M$-67.0M$-81.0M
EPS$-2.18$-3.61$-1.85$-1.76$-1.27
Op Margin—————

Balance Sheet (USD)

Metric20182019202020212022
Total Assets$82.0M$94.0M$110.0M$58.0M$19.0M
Total Liabilities$33.0M$34.0M$34.0M$36.0M$15.0M
Cash$79.0M$92.0M$72.0M$24.0M$17.0M
Borrowings$25.0M$25.0M$25.0M$25.0M$2.0M

Latest News

OP Pohjola's President and Group CEO Timo Ritakallio has announced that he will retire on 1 July 2027 as specified in his executive contract GlobeNewswire · Jul 23, 2026 Constellation Brands Shareholders Approve Directors, Pay and Incentive Plan at Annual Meeting MarketBeat · Jul 23, 2026 OP Corporate Bank plc's Half-year Financial Report 1 January–30 June 2026 GlobeNewswire · Jul 23, 2026 Asia's Largest Sustainable Seafood Event "The Sustainable Seafood Summit 2026" to Be Held from October 21 to 23, with Key Stakeholders Attending in Person PR Newswire · Jul 23, 2026 AS Tallink Grupp Unaudited Consolidated Interim Report for the Q2 2026 GlobeNewswire · Jul 23, 2026

Cash Flow (USD)

Metric20182019202020212022
Operating Cash Flow$-31.0M$-51.0M$-50.0M$-54.0M$-70.0M
Investing Cash Flow$-1.0M$0$-36.0M$3.0M$62.0M
Financing Cash Flow$64.0M$64.0M$65.0M$3.0M$32.0M
Net Cash Flow$33.0M$13.0M$-20.0M$-48.0M$-6.0M
Free Cash Flow$-31.0M$-51.0M$-50.0M$-54.0M$-70.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA0.03
FCF Yield-559.96%
Quick Ratio1.21
Interest Coverage-24.10
Return 1Y—
Return 3Y—
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMTIApplied Molecular Transport Inc. $0.26 -3.13% -0.08 $11.01M 0.00%
CYADCelyad Oncology S.A. $0.47 -12.96% -2.95 $14.24M 0.00%
GLSGelesis Holdings, Inc. $0.16 +0.00% -0.20 $11.63M 0.00%
HURA $2.09 -2.34% -3.75 $133.10M 0.00%
KRRO $10.72 +0.75% -0.80 $106.70M 0.00%

About Axcella Health Inc.

Axcella Health Inc. is a U.S.-based clinical-stage biotechnology firm focused on developing novel therapeutic compositions derived from endogenous metabolic modulators. These aim to address complex diseases and improve overall health. The company's primary drug candidates are AXA1665 and AXA1125. AXA1665 is currently undergoing Phase 2 clinical trials, where it is being evaluated for its potential to lower the risk of recurrent overt hepatic encephalopathy. Meanwhile, AXA1125 is progressing through multiple trials: a Phase 2b study targeting non-alcoholic steatohepatitis (NASH) treatment, and a Phase 2a study exploring its efficacy as a therapy for Long COVID patients. Founded in 2008, the entity initially operated as Newco LS16, Inc. before officially adopting the name Axcella Health Inc. in June 2016. Its operations are headquartered in Cambridge, Massachusetts.

Axcella Health Inc. is headquartered in US.

Axcella Health Inc. (AXLA) stock trades at $4.58 with a market capitalization of $12.50M. The stock is valued at a price-to-earnings (P/E) ratio of -3.61, price-to-book of 70.41, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.36 and $4.58, and currently trades at its 52-week high.

On profitability, Axcella Health Inc. generates a return on equity (ROE) of -620.40%, return on capital employed of -1460.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.axcellahealth.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides